10.1056/NEJMoa1515920 [DOI] [PubMed] [Google Scholar] 82
The ADA is now explicit: fibrates, niacin, and n-3 dietary supplements do not reduce cardiovascular events when added to statin therapy
Though our study provides novel information, randomised controlled trials and additional observational studies are needed to corroborate our findings, given the significant morbidity and mortality of CVEs in patients with NAFLD and type 2 diabetes
If your goal is to cut back, maintain abstinence, or create a strong deterrent to drinking, each medication is designed to solve a different problem
This result suggested that the long-acting form, unlike the short-acting forms (lixisenatide and exenatide), of exendin-4-based GLP-1RAs improved cardiovascular outcomes
Contact your PlexusDx care team or local emergency services if you experience chest pain, severe abdominal pain, confusion, or loss of consciousness